l carnitine tmao nature medicine 2013 koeth γ–Butyrobetaine is a pro-atherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO: how gut microbiota contributes
TMAO: how gut microbiota contributes to heart failure Translational Research A Multi omic Association Study of Trimethylamine N Oxide ScienceDirect Gut microbiota derived metabolites in cardiovascular health and disease Protein & Cell Springer Nature Link TMAO metaorganismal pathway and chronic inflammatory diseases Dietary Fatty Acids Modulate Gut Microbiota Derived Trimethylamine N Oxide: Potential Mechanisms and Future Perspective Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L Carnitine to TMAO ScienceDirect
Pay in 4 interest-free payments of $7.10 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4





